Blood Biomarkers for Neurodegeneration

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

93 papers

Active filtersClassification:Supporting

Showing 13-24 of total 93 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

Genetic evidence suggests a protective role of immunoglobulin M in Alzheimer's disease.

Peng S; Butler-Laporte G; Johnson SC; Engelman CD; Lu T

2026PubMedSupporting evidence

Mapping sex-specific associations of adiposity with age-related cognitive decline and multimodal Alzheimer's pathology.

Zhang J; Liu D; Yang Y; Lou X; Ren H; Tan W; Zeng Y; Alzheimer's Disease Neuroimaging Initiative, and the Hubei Memory and Aging Cohort Study

Jan 1, 2026Alzheimer's & dementia : the journal of the Alzheimer's Association

2026PubMedSupporting evidence

Serum Autophagy-Related Protein 5 and Clinically Defined Cognitive Status in Older Adults: A Plate-Stratified Cross-Sectional Study Across: Normal Cognition, Mild Cognitive Impairment, and Alzheimer's Disease.

Erdoğan K; Biçer C; Erten R; Kaya K; Boz S; Turgut Şahin H; Peker C; Dağdemir AN; Yılmaz B; Yıldırım A; Tuna Doğrul R; Selvi Öztorun H; Eken G; Sılay K

Jan 1, 2026Medicina (Kaunas, Lithuania)

2026PubMedSupporting evidence

Rethinking tau-targeted therapy in Alzheimer's disease: Toward a dual biomarker strategy.

Teunissen CE; Pini L; Imbimbo BP

Jan 1, 2026Alzheimer's & dementia : the journal of the Alzheimer's Association

2026PubMedSupporting evidence

Hinokitiol as a Potential GPX4 Allosteric Modulator to Prevent Ferroptosis-mediated Neurodegeneration in Parkinson's Disease.

Mohan D; Soujanya C; Venkatesan R; Chakkittukandiyil A; Kandy AT; Kothandan R; Balasubramanian S; Selvaraj D

Jan 1, 2026Neurochemical research

2026PubMedSupporting evidence

Bioinformatics-driven discovery and cross-cohort validation of a two-gene signature (RPH3A and HIGD1B) associated with Alzheimer's disease.

Chen F

Jan 1, 2026Computational biology and chemistry

2026PubMedSupporting evidence

Inflection points and transitions in Alzheimer's disease.

De Strooper B; Karran E

Jan 1, 2026Nature

2026PubMedSupporting evidence

Effective amyloid clearance with lecanemab in a female with Alzheimer's disease: A case report.

Noguchi-Shinohara M; Ono K

Jan 1, 2026Radiology case reports

2026PubMedSupporting evidence

Validation of plasma core biomarkers of Alzheimer's disease: A multicenter study in usual practice conditions.

Sánchez-Soblechero A; Villarejo A; Carreras MT; Berbel Á; Puertas C; Fernández-Bullido Y; Vieira A; Gundín I; Blanco-Palmero V; González-Sánchez M; Llamas S; Lapeña T; de Luis P; Lucio B; Ibáñez MD; Heredia P; Grandas F; Olazarán J

Jan 1, 2026Journal of Alzheimer's disease : JAD

2026PubMedSupporting evidence

Dynamic contributions of astrocytes in Alzheimer's disease.

Guo F; Li T; He XB

Jan 1, 2026Experimental neurology

2026PubMedSupporting evidence

Dynamic contributions of astrocytes in Alzheimer's disease.

Guo F; Li T; He XB

Jan 1, 2026Experimental neurology

2026PubMedSupporting evidence

The phenyl carbamates JBPOS0101 and JBPOS0607 attenuate rotenone-induced dopaminergic neuronal death in mice.

Lee JH; Jeong JH; Mun BR; Jang JK; Choi YM; Baek JH; Choi WS

Jan 1, 2026Brain research